Belgin P. Balcı

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD).

Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD).

Journal: Journal of neuroimmunology

Published: May 08, 2025

Sleep Disorders in Patients with Epilepsy.

Sleep Disorders in Patients with Epilepsy.

Journal: Noro psikiyatri arsivi

Published: February 12, 2024

Erratum: Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.

Erratum: Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.

Journal: Noro psikiyatri arsivi

Published: June 08, 2023

The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis.

The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: June 26, 2022

COVID-19-associated Isolated Cortical Vein Thrombosis: Detection of SARS-CoV-2 in CSF.

COVID-19-associated Isolated Cortical Vein Thrombosis: Detection of SARS-CoV-2 in CSF.

Journal: The Neurohospitalist

Published: June 24, 2022

Newly Diagnosed Tumefactive Demyelinating Lesion and Multiple Sclerosis After COVID-19 Infection.

Newly Diagnosed Tumefactive Demyelinating Lesion and Multiple Sclerosis After COVID-19 Infection.

Journal: Noro psikiyatri arsivi

Published: February 21, 2022

Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.

Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.

Journal: Noro psikiyatri arsivi

Published: December 11, 2021

Clinical and Demographic Characteristics of Immigrant and Local Multiple Sclerosis Patients in Turkey.

Clinical and Demographic Characteristics of Immigrant and Local Multiple Sclerosis Patients in Turkey.

Journal: Noro psikiyatri arsivi

Published: December 09, 2021

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Journal: Multiple sclerosis and related disorders

Published: August 12, 2021

Spasticity Measurement.

Spasticity Measurement.

Journal: Noro psikiyatri arsivi

Published: January 30, 2019

Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis.

Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: January 17, 2019

Holter Monitorisation Results in Early Period of Acute Ischemic Stroke.

Holter Monitorisation Results in Early Period of Acute Ischemic Stroke.

Journal: Noro psikiyatri arsivi

Published: March 14, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026